go back

Lisocabtagene Maraleucel (Breyanzi)

Rhode Island rates for HCPCS C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $436,516 · 10th to 90th $436,516 to $457,088Professionalmedian $446,684 · 10th to 90th $446,684 to $446,684
$500Kfacility $436,516professional $446,684

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
BCBS
Setting
Facility
Modifier
Global
Typical Low
$436,515.83
Median
$436,515.83
Typical High
$457,088.19
BCBS
Setting
Professional
Modifier
Global
Typical Low
$446,683.59
Median
$446,683.59
Typical High
$446,683.59